Investing in Kiniksa Pharmaceuticals Ltd (KNSA) Stock: Methodology
BofA Securities raised the price target for the Kiniksa Pharmaceuticals Ltd (NASDAQ:KNSA) stock to “a Buy”. The rating was released on June 29, 2020, according to finviz. The research report from Barclays has initiated the stock to Overweight, with a price target set at $26. The stock was reiterated by Wedbush, who disclosed in a […]
